UNSPSC 51182071: Testosterone enanthate

This classification denotes a therapeutic testosterone with the molecular formula C26H40O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Z6522T8N9, chemically known as 17-hydroxyandrost-4-en-3-one, 17-heptanoate but more generally known as testosterone enantate, which bears US NIH Compound Identifier 9416. European Medicines Agency schedules Testosterone enantate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04736MIG.

Most nations, for tariff and trade purposes, schedule testosterone enanthate under HS 29372900 and SITC 54153. As of Q4 2014, TESTOSTERONE ENANTHATE remains US FDA's Preferred Term for this commodity. Testosterone enanthate bears US NLM identifiers UMLS ID C0076189 and NCI Concept Code C1247. SMILES: CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.

UNSPSC 51182071 Testosterone enanthate is a Commodity code for a controlled pharmaceutical substance that state and local governments procure through health and human services departments, correctional facilities, and public health agencies for clinical and therapeutic use. The code covers testosterone enanthate as a finished pharmaceutical product, typically in injectable form, used in hormone replacement therapy, treatment of hypogonadism, and other medically indicated applications within government healthcare delivery systems.

The source provides no recent state and local contract opportunities under this code.